Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

BACKGROUND AND AIMS: In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia’s universal health care system, with the aim of HCV elimination. We report real-world effectiveness of DAA HCV treatment in Australia from a clinically well-informed cohort,...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Paul J., Valery, Patricia C., Strasser, Simone I., Weltman, Martin, Thompson, Alexander J., Levy, Miriam, Leggett, Barbara, Zekry, Amany, Rong, Julian, Angus, Peter, George, Jacob, Bollipo, Steven, McGarity, Bruce, Sievert, William, Macquillan, Gerry, Tse, Edmund, Nicoll, Amanda, Wade, Amanda, Chu, Geoff, Harding, Damian, Cheng, Wendy, Farrell, Geoff, Roberts, Stuart K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883319/
https://www.ncbi.nlm.nih.gov/pubmed/35552941
http://dx.doi.org/10.1007/s10620-022-07483-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883319/
https://www.ncbi.nlm.nih.gov/pubmed/35552941
http://dx.doi.org/10.1007/s10620-022-07483-y

Ejemplares similares